Cargando…

Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era

Sarcopenia has recently been studied in both adults and children and was found to be a prognostic marker for adverse outcome in a variety of patient groups. Our research showed that sarcopenia is a relevant marker in predicting outcome in children with solid organ tumors, such as hepatoblastoma and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritz, Annika, Lurz, Eberhard, Berger, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024674/
https://www.ncbi.nlm.nih.gov/pubmed/35455957
http://dx.doi.org/10.3390/cells11081278
_version_ 1784690662119047168
author Ritz, Annika
Lurz, Eberhard
Berger, Michael
author_facet Ritz, Annika
Lurz, Eberhard
Berger, Michael
author_sort Ritz, Annika
collection PubMed
description Sarcopenia has recently been studied in both adults and children and was found to be a prognostic marker for adverse outcome in a variety of patient groups. Our research showed that sarcopenia is a relevant marker in predicting outcome in children with solid organ tumors, such as hepatoblastoma and neuroblastoma. This was especially true in very ill, high-risk groups. Children with cancer have a higher likelihood of ongoing loss of skeletal muscle mass due to a mismatch in energy intake and expenditure. Additionally, the effects of cancer therapy, hormonal alterations, chronic inflammation, multi-organ dysfunction, and a hypermetabolic state all contribute to a loss of skeletal muscle mass. Sarcopenia seems to be able to pinpoint this waste to a high degree in a new and objective way, making it an additional tool in predicting and improving outcome in children. This article focuses on the current state of sarcopenia in children with solid organ tumors. It details the pathophysiological mechanisms behind sarcopenia, highlighting the technical features of the available methods for measuring muscle mass, strength, and function, including artificial intelligence (AI)-based techniques. It also reviews the latest research on sarcopenia in children, focusing on children with solid organ tumors.
format Online
Article
Text
id pubmed-9024674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90246742022-04-23 Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era Ritz, Annika Lurz, Eberhard Berger, Michael Cells Review Sarcopenia has recently been studied in both adults and children and was found to be a prognostic marker for adverse outcome in a variety of patient groups. Our research showed that sarcopenia is a relevant marker in predicting outcome in children with solid organ tumors, such as hepatoblastoma and neuroblastoma. This was especially true in very ill, high-risk groups. Children with cancer have a higher likelihood of ongoing loss of skeletal muscle mass due to a mismatch in energy intake and expenditure. Additionally, the effects of cancer therapy, hormonal alterations, chronic inflammation, multi-organ dysfunction, and a hypermetabolic state all contribute to a loss of skeletal muscle mass. Sarcopenia seems to be able to pinpoint this waste to a high degree in a new and objective way, making it an additional tool in predicting and improving outcome in children. This article focuses on the current state of sarcopenia in children with solid organ tumors. It details the pathophysiological mechanisms behind sarcopenia, highlighting the technical features of the available methods for measuring muscle mass, strength, and function, including artificial intelligence (AI)-based techniques. It also reviews the latest research on sarcopenia in children, focusing on children with solid organ tumors. MDPI 2022-04-09 /pmc/articles/PMC9024674/ /pubmed/35455957 http://dx.doi.org/10.3390/cells11081278 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ritz, Annika
Lurz, Eberhard
Berger, Michael
Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
title Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
title_full Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
title_fullStr Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
title_full_unstemmed Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
title_short Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
title_sort sarcopenia in children with solid organ tumors: an instrumental era
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024674/
https://www.ncbi.nlm.nih.gov/pubmed/35455957
http://dx.doi.org/10.3390/cells11081278
work_keys_str_mv AT ritzannika sarcopeniainchildrenwithsolidorgantumorsaninstrumentalera
AT lurzeberhard sarcopeniainchildrenwithsolidorgantumorsaninstrumentalera
AT bergermichael sarcopeniainchildrenwithsolidorgantumorsaninstrumentalera